Quanterix Corporation (QTRX)

Market Cap	158.61M -20.7%
Revenue (ttm)	138.90M +1.1%
Net Income	-107.15M
EPS	-2.51
Shares Out	47.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	456,354
Open	3.330
Previous Close	3.400
Day's Range	3.280 - 3.470
52-Week Range	2.950 - 8.770
Beta	1.15
Analysts	Hold
Price Target	6.00 (+78.04%)
Earnings Date	May 6, 2026

About QTRX

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company’s products include assays include all components required to run enzyme-based immunoassay, s...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 7, 2017
• Employees: 450
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX
• Website: https://www.quanterix.com

Financial Performance

In 2025, Quanterix's revenue was $138.90 million, an increase of 1.07% compared to the previous year's $137.42 million. Losses were -$107.15 million, 178.1% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for QTRX stock is "Hold." The 12-month stock price target is $6.0, which is an increase of 78.04% from the latest price.

Price Target

$6.0

(78.04% upside)

Analyst Consensus: Hold